🟢 Intervacc is trading 20% up on November 4, 2026, after reporting 0.006% incidence in vaccinated horses

Intervacc is trading at €0.06, up 20.08%, after announcing real-world Strangvac data on November 3, including a calculated 0.006% incidence among horses completing primary vaccination.

• The company identified 3 confirmed infections among horses completing primary vaccination, after 100,000 doses had been sold in the EU and UK.
• No trading-volume information was available in the cited sources; the Q3 report is scheduled for November 12.